Concepedia

Author

Ludovic Malvaux

GlaxoSmithKline (Belgium)

Also Known As

Ludovic Malvaux, Malvaux, Ludovic

26

Publications

1K

Citations

10

H-Index

52

Concepts

All Affiliations

GlaxoSmithKline (Belgium)University of LiègeGlaxoSmithKline (United States)Sangamo BioSciences (United States)Regeneron (United States)
LM

About

Ludovic Malvaux is an author at GlaxoSmithKline (Belgium) specializing in medicine, cell biology, and vascular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

5

693

2

Cell Biology

3

3

541

3

Engineering

2

2

496

4

Cellular Therapies

1

1

14

5

Epidemiology

1

2

152

Ludovic Malvaux

×

9

Publications

946

Citations

9

H-Index

YearCitations

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

Julie Halkein, Sébastien P. Tabruyn, Melanie Ricke‐Hoch,

Journal of Clinical Investigation

2013

482

MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells

Céline Sabatel, Ludovic Malvaux, Nicolas Bovy,

PLoS ONE

2011

250

Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

Carine Claeys, Khalequ Zaman, Ghassan Dbaibo,

The Lancet Child & Adolescent Health

2018

76

The Angiostatic 16K Human Prolactin Overcomes Endothelial Cell Anergy and Promotes Leukocyte Infiltration via Nuclear Factor-κB Activation

Sébastien P. Tabruyn, Céline Sabatel, Ngoc-Quynh-Nhu Nguyen,

Molecular Endocrinology

2007

45

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis

Céline Sabatel, Anne Cornet, Sébastien P. Tabruyn,

Molecular Cancer

2010

28

Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America

Sonia Schoonbroodt, Jean-Laurent Ichanté, Sophie Boffé,

Frontiers in Microbiology

2023

21

Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific

Laura Taddei, Lucio Malvisi, David S.C. Hui,

ERJ Open Research

2022

18

2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp &amp; Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, Ada Affinity, Risk-Based Approaches, Ngs, Qpcr, Ddpcr Assays ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity &amp; Technologies; Immunogenicity &amp; Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach)

Luying Pan, Johanna Mora, Karl Walravens,

Bioanalysis

2023

14

2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles <u>Part 2</u> – Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development &amp; Validation; Emerging Technologies; Critical Reagents Deep Characterization

Giane Sumner, Steve Keller, James W. Huleatt,

Bioanalysis

2023

12

Page 1